查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2014371

臍帶血庫服務市場：2026-2032年全球市場預測（按服務類型、處理方法、交付方式、儲存期限、細胞類型、應用和最終用戶分類）

Cord Blood Banking Services Market by Service Type, Processing Method, Delivery Mode, Storage Duration, Cell Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，臍帶血庫服務市場價值將達到 416.9 億美元，到 2026 年將成長至 468.1 億美元，到 2032 年將達到 1,008.3 億美元，複合年成長率為 13.44%。

主要市場統計數據
基準年 2025 416.9億美元
預計年份：2026年 468.1億美元
預測年份 2032 1008.3億美元
複合年成長率 (%) 13.44%

本文重點介紹臍帶血庫在臨床創新、營運複雜性、監管變化和相關人員決策架構下的發展。

臍帶血庫處於臨床創新、以病人為中心的照護和複雜運作結構交匯的獨特位置。過去十年，幹細胞科學和轉化醫學的進步提高了人們對臍帶血療法的期望，而採集、處理和冷凍保存技術的改進則為臨床醫生和家庭提供了更多實際選擇。同時，不斷發展的法規結構以及對品質和可追溯性日益成長的需求，也重新定義了整個產業的營運標準。

分析正在重塑臍帶血服務的採集、處理、儲存和管治的變革性技術、臨床和監管變化。

臍帶血庫產業正經歷著變革性的轉變，這主要得益於技術的成熟、臨床模式的轉變以及監管環境的日益完善。技術進步縮短了處理時間，提高了細胞活力指標，從而促進了新治療方法的探索，並擴大了臨床適應症的研究範圍。同時，用於供體追蹤、知情同意管理和生物庫庫存管理的數位化平台的整合，提高了透明度和營運效率，進而提升了可追溯性和品質保證水準。

仔細評估 2025 年美國關稅政策變化將如何影響整個臍帶血產業的採購、物流和風險管理趨勢。

2025年美國關稅政策的變化為全球醫療用品供應鏈和生物材料跨境運輸帶來了新的複雜性。這些措施正直接影響臍帶血業務所需的耗材、冷凍保存設備和診斷試劑供應商，以及用於研發和臨床的生物檢體的國際運輸。事實上，關稅導致的成本調整正在改變籌資策略，促使企業重新評估供應商多元化，並盡可能與國內製造商建立更緊密的採購關係。

以細分為導向的全面觀點，將服務模式、臨床應用、最終用戶、處理方法和細胞產品類型與實際操作選擇相結合。

在臍帶血庫領域，對細分市場的深入了解對於制定有針對性的服務提案和臨床路徑至關重要。根據服務類型，臍帶血庫的營運模式分為混合型、私人型和公立型，每種模式都有其獨特的商業性邏輯、知情同意框架和相關人員關係，這些因素會影響註冊數量、定價結構和合作機會。根據應用領域，市場涵蓋再生醫學、研究和移植。再生醫學在心血管、肌肉骨骼和神經系統疾病方面的需求不斷成長，這需要特定的處理標準和細胞富集技術。研究應用分為學術研究和商業研究；學術研究致力於基礎發現，而商業項目則著重於產品開發和轉化應用。移植應用包括血液系統疾病、免疫系統疾病和腫瘤疾病，這些疾病的儲存和取得均受臨床方案和適用性要求的約束。

深入了解監管多樣性、醫療保健基礎設施和本地製造能力如何影響臍帶血在全球主要市場的引入，包括區域差異。

區域趨勢在塑造臍帶血服務的監管預期、合作夥伴生態系統和推廣路徑方面發揮著至關重要的作用。在美洲，國家監管機構和保險公司在建立臨床應用和推廣路徑方面扮演核心角色，大規模醫療保健網路通常是與臨床醫生合作以及進行病患宣傳宣傳活動的主要管道。此外，美洲擁有強大的醫療用品國內生產能力，這會影響籌資策略和業務永續營運計畫。

評估市場參與企業之間的競爭與合作行為：重點在於策略投資領域、夥伴關係模式與營運差異化因素。

臍帶血領域的競爭動態取決於服務品質、臨床夥伴關係、技術能力和可靠性等因素的綜合作用。領先機構已投資建置端對端可追溯系統、嚴格的品管系統以及專有的處理技術，以提升儲存臍帶血的臨床效用。與大學附屬醫院、臨床研究網路和醫療設備製造商建立策略合作夥伴關係，是展示實際療效和確保轉診途徑的關鍵機制。

為實現永續成長，提出切實可行的策略建議，包括整合供應鏈韌性、數位化、臨床證據產生和夥伴關係主導的能力建構。

產業領導企業應優先考慮那些既能確保短期營運穩健性，又能兼顧長期臨床和商業性定位的投資。首先，應透過多元化關鍵供應商、確保低溫設備和耗材的冗餘，以及實施反映新貿易情勢的合約保障措施，來增強供應鏈的韌性。這些措施將有助於降低採購衝擊帶來的風險，並為策略性採購決策創造更多空間。

我們採用透明的混合方法研究方法，結合對關鍵相關人員的訪談、二手文獻的整合和系統的檢驗，獲得了可操作的見解。

本分析的調查方法融合了質性訪談、二手文獻和系統性的資料檢驗，以確保研究結果的穩健性和相關性。主要研究包括對臨床負責人、營運經理和監管專家進行結構化訪談，以了解實際應用中的限制因素、新興用例和推廣障礙。這些訪談內容經過主題編碼，以確保所獲得的營運洞察反映的是真實情況而非理論概念。

將技術進步、卓越營運和證據生成與臍帶血服務的未來臨床和商業性可行性聯繫起來，得出簡潔的結論。

總之，臍帶血庫正處於一個轉折點，技術進步、臨床應用的變化以及監管期望的演變在此交匯，有可能重新定義其價值提案。那些能夠將嚴格的品管、有針對性的臨床證據產生以及靈活的供應鏈策略相結合的機構，將更有能力將科學潛力轉化為永續的臨床效用。不斷變化的收費系統和貿易環境凸顯了韌性和在地採購選項的重要性，而數位平台的進步則促進了家庭、臨床醫生和生物庫之間更順暢的合作。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：臍帶血庫服務市場：依服務類型分類

  • 私人臍帶血庫
  • 公共臍帶血庫

第9章 依處理方法分類的臍帶血庫服務市場

  • 單核細胞的分離
  • MSC富集
  • 產能下降

第10章：臍帶血庫服務市場：依交付方式分類

  • 異地收集
  • 現場收集

第11章 依儲存期分類的臍帶血庫服務市場

  • 長期儲存
  • 短期儲存

第12章 臍帶血庫服務市場（依細胞類型分類）

  • CD34陽性細胞
  • 有核細胞總數

第13章 臍帶血庫服務市場：依應用領域分類

  • 再生醫學
    • 心血管系統
    • 肌肉骨骼系統
    • 神經系統
  • 調查
    • 學術的
    • 商業的
  • 移植
    • 血液疾病
    • 免疫疾病
    • 腫瘤性疾病

第14章 臍帶血庫服務市場：依最終用戶分類

  • 診所
  • 醫院
  • 研究機構

第15章：臍帶血庫服務市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章 臍帶血庫服務市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 臍帶血庫服務市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章：美國臍帶血庫服務市場

第19章：中國臍帶血庫服務市場

第20章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AlphaCord, LLC
  • Americord Registry, LLC
  • Cells4Life Limited
  • China Cord Blood Corporation
  • Cord Blood Registry, LLC
  • Cord for Life, LLC
  • Cordlife Group Limited
  • Cryo-Cell International, Inc.
  • Cryoholdco LLC
  • Cryoviva Healthcare Private Limited
  • CSG-BIO, Inc.
  • FamiCord SA
  • Life Sciences
  • LifeCell International Private Limited
  • Medipost Co., Ltd.
  • StemCyte, Inc.
  • Vcanbio Cell & Gene Engineering Corp.
  • ViaCord, LLC
  • Vita 34 AG
Product Code: MRR-4311CE1A33C4

The Cord Blood Banking Services Market was valued at USD 41.69 billion in 2025 and is projected to grow to USD 46.81 billion in 2026, with a CAGR of 13.44%, reaching USD 100.83 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 41.69 billion
Estimated Year [2026] USD 46.81 billion
Forecast Year [2032] USD 100.83 billion
CAGR (%) 13.44%

A focused introduction that situates cord blood banking within clinical innovation, operational complexity, regulatory evolution, and stakeholder decision frameworks

Cord blood banking occupies a distinctive intersection of clinical innovation, patient-centric care, and complex operational delivery. Over the past decade, advances in stem cell science and translational medicine have strengthened the therapeutic promise of cord blood-derived products, while improvements in collection, processing, and cryostorage have expanded practical options for clinicians and families alike. At the same time, evolving regulatory frameworks and heightened expectations around quality and traceability have redefined operational benchmarks across the sector.

This introduction situates the reader within the prevailing ecosystem by clarifying the principal service models, clinical and research applications, and typical end-user interactions that shape decision-making. It foregrounds the interplay between scientific opportunity and logistical realities, emphasizing how governance, reimbursement dynamics, and institutional partnerships influence adoption pathways. With a focus on actionable context rather than speculative optimism, the narrative establishes the parameters for subsequent analysis and underlines the core drivers that stakeholders must monitor to maintain resilience and agility in a rapidly maturing market.

An analysis of the transformative technological, clinical, and regulatory shifts reshaping how cord blood services are collected, processed, stored, and governed

The cord blood banking landscape is experiencing transformative shifts driven by technological maturation, shifting clinical paradigms, and a more sophisticated regulatory environment. Technological advances have reduced processing time and improved cell viability metrics, enabling new therapeutic explorations and expanding the range of clinical indications under investigation. Concurrently, the integration of digital platforms for donor tracking, consent management, and biobank inventory control is improving transparency and operational efficiency, which in turn supports higher standards of traceability and quality assurance.

Clinical paradigms are also changing as regenerative medicine applications and cell therapy research increasingly intersect with traditional transplantation pathways. This convergence broadens the potential utility of stored cord blood units while requiring biobanks to refine their processing and storage protocols to meet diverse downstream needs. Regulatory authorities are responding with more defined guidance on Good Tissue Practice, data governance, and cross-border logistics, prompting providers to invest in compliance systems and standardized documentation. Taken together, these shifts are fostering a more professionalized market environment where strategic partnerships, interoperability, and demonstrable outcomes are becoming the primary differentiators among providers.

A measured assessment of how United States tariff policy changes in 2025 have altered procurement, logistics, and risk management dynamics across cord blood operations

Tariff policy developments in the United States in 2025 introduced a new layer of complexity into global supply chains for medical goods and cross-border biological material movement. These measures have immediate implications for suppliers of consumables, cryopreservation equipment, and diagnostic reagents that support cord blood operations, as well as for international transfers of biological samples for research and clinical use. In practice, tariff-driven cost adjustments have altered procurement strategies, prompting a reassessment of supplier diversification and incentivizing closer sourcing relationships with domestic manufacturers where feasible.

Operational consequences extend beyond direct cost impacts to include shifts in logistics planning, customs clearance processes, and contract terms with international partners. Organizations that previously relied on lean global supply chains are re-evaluating inventory policies and buffer stocks to protect continuity of services. In addition, tariffs have encouraged some stakeholders to accelerate onshoring of critical manufacturing and to renegotiate service level agreements that better reflect current trade risks. From a strategic perspective, the tariff environment underscores the importance of scenario planning, supplier risk assessment, and adaptive procurement frameworks that can mitigate disruption while maintaining clinical and research continuity.

A comprehensive segmentation-driven perspective that aligns service models, clinical applications, end users, processing methods, and cellular product types to practical operating choices

Segment-level understanding is pivotal to crafting targeted service propositions and clinical pathways in cord blood banking. Based on Service Type, providers operate across hybrid, private, and public models, each presenting distinct commercial logics, consent frameworks, and stakeholder relationships that influence enrollment, pricing structures, and partnership opportunities. Based on Application, the market spans regenerative medicine, research, and transplantation. Regenerative medicine demand is being developed across cardiovascular, musculoskeletal, and neurological indications, requiring specific processing standards and cell enrichment approaches. Research applications are divided between academic and commercial research, with academic work driving fundamental discovery and commercial programs focused on product development and translational pipelines. Transplantation use cases include hematological disorders, immunological disorders, and oncological disorders, where clinical protocols and compatibility requirements dictate storage and retrieval practices.

Based on End User, activities are organized around clinics, hospitals, and research institutes, each demanding different engagement models, service level agreements, and reporting requirements. Based on Delivery Mode, collection strategies vary between off site collection and on site collection, affecting logistics, parental engagement, and chain-of-custody management. Based on Processing Method, laboratories deploy mononuclear cell isolation, MSC enrichment, and volume reduction techniques to prepare units for intended applications, and these methods have direct implications for yield, product specification, and downstream usability. Based on Storage Duration, facilities manage both long term storage and short term storage needs that reflect clinical readiness and research timelines. Based on Cell Type, cord blood services commonly differentiate handling for CD34 positive cells versus total nucleated cells, with processing, quality control, and release criteria aligned to the intended clinical or investigational use. Together, these segmentation lenses provide a comprehensive map for tailoring operational design, R&D prioritization, and market access activities.

Regionally nuanced insights into how regulatory diversity, healthcare infrastructure, and local manufacturing capacity influence cord blood adoption across major global markets

Regional dynamics play a critical role in shaping regulatory expectations, partner ecosystems, and adoption pathways for cord blood services. In the Americas, national regulatory agencies and payers are central to establishing pathways for clinical translation and adoption, and large healthcare networks often provide the primary points of clinician engagement and patient awareness campaigns. The Americas region also has notable capacity for domestic manufacturing of medical supplies, which influences procurement strategies and resilience planning.

In Europe, Middle East & Africa, regulatory heterogeneity and varying healthcare infrastructures require flexible commercialization approaches that emphasize compliance harmonization, localized partnerships, and tailored pricing strategies. Cross-border collaboration within this region often depends on mutual recognition frameworks and data transfer agreements that support research consortia and multicenter trials. Asia-Pacific presents a mix of rapid clinical adoption in some markets and nascent research development in others, with strong private-sector investment and growing biomanufacturing capabilities. Each region demonstrates unique strengths and constraints that influence decisions about where to prioritize clinical programs, where to invest in infrastructure, and how to design go-to-market models that accommodate local regulatory and reimbursement realities.

An appraisal of competitive and collaborative behaviours among market participants that highlights strategic investment areas, partnership models, and operational differentiators

Competitive dynamics in the cord blood arena are defined by a combination of service quality, clinical partnerships, technological capability, and reputational trust. Leading organizations have invested in end-to-end traceability systems, rigorous quality management, and proprietary processing techniques that enhance the clinical utility of stored units. Strategic collaborations with academic medical centers, clinical research networks, and device manufacturers have become important mechanisms for demonstrating real-world outcomes and securing referral pathways.

Mergers, partnerships, and vertical integration are observable strategies among market participants seeking to secure supply chains, broaden service offerings, and accelerate clinical validation. Investment in digital capabilities-covering consent management, cloud-based inventory control, and telemedicine-enabled client engagement-has emerged as a differentiator that improves customer experience and operational transparency. At the same time, smaller and specialized providers distinguish themselves through niche clinical focus, bespoke processing protocols, or deep relationships with regional healthcare systems. For stakeholders evaluating potential partners, the emphasis should be on validated quality systems, clinical evidence generation, and an ability to scale services in a compliant manner while preserving patient-centric care models.

Actionable strategic recommendations that blend supply chain resilience, digital modernization, clinical evidence generation, and partnership-driven capacity building for sustained growth

Industry leaders should prioritize investments that balance near-term operational robustness with long-term clinical and commercial positioning. First, strengthen supply chain resilience by diversifying critical suppliers, establishing redundancy for cryogenic equipment and consumables, and implementing contractual protections that reflect new trade realities. Such actions reduce exposure to procurement shocks and provide breathing room for strategic sourcing decisions.

Second, accelerate digital transformation to improve consent capture, chain-of-custody visibility, and client communication. Digital systems that integrate with electronic health records and support secure data exchange will streamline enrollment and retrieval workflows, enhancing clinician and patient satisfaction. Third, invest in targeted clinical evidence generation by sponsoring rigorous trials and observational studies across prioritized regenerative and transplantation indications; outcomes data will be decisive in payer discussions and clinical adoption. Fourth, pursue regulatory alignment and proactive compliance by engaging with authorities early, harmonizing quality systems to international standards, and documenting end-to-end traceability. Finally, cultivate strategic partnerships across academic centers, device suppliers, and logistics providers to create vertically integrated pathways from collection to therapeutic application. Collectively, these recommendations position organizations to capture emerging opportunities while mitigating operational and regulatory risks.

A transparent mixed-methods research approach combining primary stakeholder interviews, secondary literature synthesis, and systematic validation to produce actionable findings

The research methodology underpinning this analysis integrates primary qualitative interviews, secondary literature synthesis, and systematic data validation to ensure robustness and relevance. Primary engagement included structured interviews with clinical leaders, operational managers, and regulatory specialists to capture real-world constraints, emerging use cases, and adoption barriers. These conversations informed thematic coding and ensured that operational insights reflected pragmatic realities rather than theoretical constructs.

Secondary research encompassed review of peer-reviewed literature, regulatory guidance documents, technical white papers, and vendor specifications to triangulate technology trends and compliance expectations. Findings from primary and secondary sources were reconciled through cross-validation exercises, where discrepant inputs were resolved by returning to subject-matter experts or by examining recent regulatory announcements for clarification. The approach prioritized transparency in assumptions, reproducibility of analytic steps, and traceable linkage between evidence and implication. Ethical considerations and data privacy were embedded throughout the methodology, with attention to anonymization where interviewees provided proprietary or sensitive operational details. This mixed-methods approach supports a balanced, evidence-driven perspective that is actionable for commercial, clinical, and policy audiences.

A concise concluding synthesis that links technological progress, operational excellence, and evidence generation to the future clinical and commercial viability of cord blood services

In conclusion, cord blood banking stands at an inflection point where technological progress, shifting clinical applications, and evolving regulatory expectations are converging to redefine value propositions. Organizations that combine rigorous quality management, targeted clinical evidence generation, and adaptive supply chain strategies will be best positioned to translate scientific potential into sustained clinical utility. The evolving tariff and trade environment highlights the importance of resilience and local sourcing options, while advances in digital platforms are enabling more seamless interactions between families, clinicians, and biobanks.

Strategic clarity around segmentation-service model, application focus, end-user engagement, delivery mode, processing method, storage duration, and cell type-will enable providers to align capabilities to market needs and to pursue partnerships that amplify clinical impact. Ultimately, pragmatic investment in operational excellence, regulatory alignment, and evidence-based clinical programs will generate the credibility and performance required to realize the broader promise of cord blood-derived therapies and research initiatives.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cord Blood Banking Services Market, by Service Type

  • 8.1. Private Cord Blood Banks
  • 8.2. Public Cord Blood Banks

9. Cord Blood Banking Services Market, by Processing Method

  • 9.1. Mononuclear Cell Isolation
  • 9.2. MSC Enrichment
  • 9.3. Volume Reduction

10. Cord Blood Banking Services Market, by Delivery Mode

  • 10.1. Off Site Collection
  • 10.2. On Site Collection

11. Cord Blood Banking Services Market, by Storage Duration

  • 11.1. Long Term Storage
  • 11.2. Short Term Storage

12. Cord Blood Banking Services Market, by Cell Type

  • 12.1. CD34 Positive Cells
  • 12.2. Total Nucleated Cells

13. Cord Blood Banking Services Market, by Application

  • 13.1. Regenerative Medicine
    • 13.1.1. Cardiovascular
    • 13.1.2. Musculoskeletal
    • 13.1.3. Neurological
  • 13.2. Research
    • 13.2.1. Academic
    • 13.2.2. Commercial
  • 13.3. Transplantation
    • 13.3.1. Hematological Disorders
    • 13.3.2. Immunological Disorders
    • 13.3.3. Oncological Disorders

14. Cord Blood Banking Services Market, by End User

  • 14.1. Clinics
  • 14.2. Hospitals
  • 14.3. Research Institutes

15. Cord Blood Banking Services Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Cord Blood Banking Services Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Cord Blood Banking Services Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Cord Blood Banking Services Market

19. China Cord Blood Banking Services Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. AlphaCord, LLC
  • 20.6. Americord Registry, LLC
  • 20.7. Cells4Life Limited
  • 20.8. China Cord Blood Corporation
  • 20.9. Cord Blood Registry, LLC
  • 20.10. Cord for Life, LLC
  • 20.11. Cordlife Group Limited
  • 20.12. Cryo-Cell International, Inc.
  • 20.13. Cryoholdco LLC
  • 20.14. Cryoviva Healthcare Private Limited
  • 20.15. CSG-BIO, Inc.
  • 20.16. FamiCord S.A.
  • 20.17. Life Sciences
  • 20.18. LifeCell International Private Limited
  • 20.19. Medipost Co., Ltd.
  • 20.20. StemCyte, Inc.
  • 20.21. Vcanbio Cell & Gene Engineering Corp.
  • 20.22. ViaCord, LLC
  • 20.23. Vita 34 AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CORD BLOOD BANKING SERVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CORD BLOOD BANKING SERVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES CORD BLOOD BANKING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA CORD BLOOD BANKING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY PRIVATE CORD BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY PRIVATE CORD BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY PRIVATE CORD BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY PUBLIC CORD BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY PUBLIC CORD BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY PUBLIC CORD BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY MONONUCLEAR CELL ISOLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY MONONUCLEAR CELL ISOLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY MONONUCLEAR CELL ISOLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY MSC ENRICHMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY MSC ENRICHMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY MSC ENRICHMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY VOLUME REDUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY VOLUME REDUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY VOLUME REDUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY OFF SITE COLLECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY OFF SITE COLLECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY OFF SITE COLLECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY ON SITE COLLECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY ON SITE COLLECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY ON SITE COLLECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY LONG TERM STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY LONG TERM STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY LONG TERM STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY SHORT TERM STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY SHORT TERM STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY SHORT TERM STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CD34 POSITIVE CELLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CD34 POSITIVE CELLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CD34 POSITIVE CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY TOTAL NUCLEATED CELLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY TOTAL NUCLEATED CELLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY TOTAL NUCLEATED CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY MUSCULOSKELETAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY MUSCULOSKELETAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY MUSCULOSKELETAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY NEUROLOGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY NEUROLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY NEUROLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY ACADEMIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY ACADEMIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY ACADEMIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY COMMERCIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY COMMERCIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY ONCOLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY ONCOLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY ONCOLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. GCC CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. GCC CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. GCC CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2032 (USD MILLION)
  • TABLE 191. GCC CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 192. GCC CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 193. GCC CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. GCC CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. GCC CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 196. GCC CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 197. GCC CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 198. GCC CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. G7 CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. G7 CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. G7 CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2032 (USD MILLION)
  • TABLE 224. G7 CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 225. G7 CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 226. G7 CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. G7 CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. G7 CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 229. G7 CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 230. G7 CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 231. G7 CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. NATO CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 233. NATO CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. NATO CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2032 (USD MILLION)
  • TABLE 235. NATO CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 236. NATO CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 237. NATO CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. NATO CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 239. NATO CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 240. NATO CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 241. NATO CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 242. NATO CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES CORD BLOOD BANKING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA CORD BLOOD BANKING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)